The world's longest preoperative ECMO lung transplant patients with new coronary pneumonia resume spontaneous breathing

(Fighting against New Coronary Pneumonia) Recover spontaneous breathing in patients with new coronary pneumonia lung transplants who have been using ECMO for the longest time before surgery worldwide

　　China News Agency, Wuhan, May 9 (Nie Wenwen, Ma Furong) The Union Hospital of Huazhong University of Science and Technology announced on the 9th that the newest coronary artery pneumonia nucleic acid patients with the longest preoperative auxiliary time using artificial lung membrane (ECMO) treated by the hospital Liu Qiang (pseudonym) recovered well after receiving double lung transplantation, and has left ECMO to resume spontaneous breathing.

　　54-year-old Liu Qiang was diagnosed with New Coronary Pneumonia at the end of January. He received ECMO treatment on February 11 due to his worsening condition. ECMO, commonly known as artificial lung, is mainly used to provide continuous extracorporeal breathing and circulation to patients with severe cardiopulmonary failure to maintain patient life.

　　After treatment with anti-virus, anti-infection, improved immunity, plasma during rehabilitation period, prone position ventilation, etc., Liu Qiangxin recovered from coronary pneumonia, but the virus caused him to develop irreversible extensive pulmonary interstitial fibrosis, which could not be sustained by conventional treatment alone. The next chance is lung transplantation.

　　More than 20 experts from the Chinese intensive care department, organ transplant center and other related fields have repeatedly discussed the lung transplant surgery plan. Before the operation, the medical team carefully took care to help Liu Qiang to correct the coagulation dysfunction, etc., and also completed a series of examinations such as viral nucleic acid detection, various matching tests, and functional evaluation of various organ systems.

　　After waiting, the lung donated by a Shandong brain-dead patient matched Liu Qiang successfully. On April 24, the donor arrived in Wuhan. The multidisciplinary team worked closely to complete the double lung transplantation in five and a half hours.

　　Dong Nianguo, director of the Organ Transplantation Center of the Union Hospital of Huazhong University of Science and Technology, pointed out that the patient is currently the world's longest patient with ECMO-assisted neonatal pneumonia nucleic acid before the lung transplant operation (73 days). Long-term use of large doses of antibiotics, dialysis treatment, etc. In addition, patients have problems with the coagulation system and lung adhesions, which also increase the difficulty of surgery.

　　After the operation, after two blood clot removals and 12 bronchoscopy examinations, Liu Qiang successfully withdrew ECMO recently. Since then, he has successively passed through the dangers of bleeding, shock, infection, lung ischemia-reperfusion injury and rejection, stress ulcers, etc. At present, his vital signs are stable, the function of lung transplantation is good, and he can actively communicate with medical staff.

　　According to Dong Nianguo, Liu Qiang is gradually recovering. Next, he needs to cross the breathing, rejection, and infection levels. "We will do a good job in postoperative rehabilitation management to help him recover from the hospital as soon as possible."